Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$5.61 - $12.01 $2.33 Million - $4.98 Million
-414,959 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$6.99 - $9.26 $3.61 Million - $4.78 Million
-516,241 Reduced 55.44%
414,959 $3.27 Million
Q3 2020

Nov 12, 2020

BUY
$8.49 - $19.54 $5.42 Million - $12.5 Million
638,200 Added 217.82%
931,200 $7.91 Million
Q2 2020

Aug 13, 2020

BUY
$7.44 - $11.29 $2.18 Million - $3.31 Million
293,000 New
293,000 $3.05 Million
Q3 2019

Nov 14, 2019

SELL
$19.17 - $27.4 $5.9 Million - $8.44 Million
-307,967 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.93 - $42.84 $7.06 Million - $13.2 Million
307,967 New
307,967 $0

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $939M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.